EpiCept is focused on developing products, that target unmet needs in cancer treatments and pain management. We are actively seeking partners to strengthen our business by either expanding our internal portfolio of compounds through in-licensing or select acquisitions, or collaborating in the development and commercialization of our drug candidates through co-development, out-licensing or marketing alliances.

If you are interested in discussing potential partnering or licensing opportunities, please contact:

• Jack Talley
  President, Chief Executive Officer
  EpiCept Corporation
  777 Old Saw Mill River Road
  Tarrytown, New York 10591
  Tel: 914-606-3500
  Fax: 914-606-3501
  Email: jtalley@epicept.com